AMEDISYS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Amedisys Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q4 2024.
  • Amedisys Inc Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$20.4M, a 205% decline year-over-year.
  • Amedisys Inc Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $43.2M.
  • Amedisys Inc annual Net Income (Loss) Attributable to Parent for 2024 was $43.2M.
  • Amedisys Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$9.75M, a 108% decline from 2022.
  • Amedisys Inc annual Net Income (Loss) Attributable to Parent for 2022 was $119M, a 43.3% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $43.2M -$20.4M -$39.7M -205% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $82.9M $16.9M -$9.05M -34.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $92M $32.3M +$113M Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 -$20.6M $14.4M -$10.8M -43% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 -$9.75M $19.3M -$12.4M -39.1% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $2.65M $26M +$318K +1.24% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.33M -$80.3M -$110M -371% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 $112M $25.2M -$6.43M -20.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $119M $31.7M -$2.33M -6.84% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $121M $25.6M -$19.4M -43% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-25
Q2 2022 $140M $29.6M -$50.6M -63.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $191M $31.7M -$18.2M -36.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $209M $34M -$11.1M -24.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $220M $45M -$27M -37.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $247M $80.1M +$45.5M +131% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $202M $49.9M +$18.1M +56.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $184M $45.1M +$17.4M +62.8% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 $166M $72M +$37.9M +111% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $128M $34.7M +$974K +2.89% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $127M $31.8M +$502K +1.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $127M $27.7M +$200K +0.73% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $127M $34.1M +$2.7M +8.6% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 $124M $33.7M +$400K +1.2% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 $124M $31.3M +$4.1M +15.1% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 $119M $27.5M +$31.3M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-19
Q3 2018 $88.1M $31.4M +$16.8M +115% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-19
Q2 2018 $71.3M $33.3M +$28.8M +640% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-19
Q1 2018 $42.5M $27.2M +$12.1M +80.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-19
Q4 2017 $30.4M -$3.8M -$12.7M -143% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 $43.1M $14.6M +$3.2M +28.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 $39.9M $4.5M -$6.2M -57.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 $46.1M $15.1M +$8.9M +144% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 $37.2M $8.9M -$4M -31% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-28
Q3 2016 $41.2M $11.4M +$3M +35.7% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-28
Q2 2016 $38.2M $10.7M +$100K +0.94% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-28
Q1 2016 $38.1M $6.2M +$41.2M Jan 1, 2016 Mar 31, 2016 10-K 2018-02-28
Q4 2015 -$3.1M $12.9M +$3.8M +41.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 -$6.9M $8.4M $0 0% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 -$6.9M $10.6M +$3M +39.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 -$9.9M -$35M -$22.6M -182% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 $12.7M $9.1M +$18.7M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 -$6M $8.4M +$99.5M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 -$106M $7.6M +$5.8M +322% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 -$111M -$12.4M -$15.1M -559% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 -$96.2M -$9.6M +$97.2M +91% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-04
Q3 2013 -$193M -$91.1M -$101M -1020% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-04
Q2 2013 -$92.4M $1.8M -$6.1M -77.2% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-04
Q1 2013 -$86.3M $2.7M -$2.7M -50% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-04
Q4 2012 -$83.6M -$107M -$111M -2584% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-12
Q3 2012 $27.5M $9.9M +$434M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-12
Q2 2012 -$406M $7.9M -$13.7M -63.4% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-12
Q1 2012 -$392M $5.4M -$9.9M -64.7% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-12
Q4 2011 -$383M $4.3M -$17.9M -80.6% Oct 1, 2011 Dec 31, 2011 10-K 2013-03-12
Q3 2011 -$365M -$424M -$445M -2062% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-12
Q2 2011 $80.7M $21.6M -$10.6M -32.9% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-12
Q1 2011 $91.3M $15.3M -$21.3M -58.2% Jan 1, 2011 Mar 31, 2011 10-K 2013-03-12
Q4 2010 $113M $22.2M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-28
Q3 2010 $21.6M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-28
Q2 2010 $32.2M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-28
Q1 2010 $36.6M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.